This is the relevant text from the financial news article:
India’s largest drugmaker Sun Pharmaceutical Industries has recalled testosterone cypionate for injection in the US, data on US Food and Drug Administration (FDA) website released Wednesday showed. Testosterone cypionate, used to treat low testosterone levels in men and in hormone therapy for transgender men, was manufactured by Sun Pharma at one of the company’s plants in Gujarat.
Testosterone cypionate was a voluntary class II recall, the data showed. A recall is designated class II if exposure to a product may cause temporary or medically-reversible adverse health consequences.
India’s largest drugmaker Sun Pharmaceutical Industries has recalled testosterone cypionate for injection in the US, data on US Food and Drug Administration (FDA) website released Wednesday showed. Testosterone cypionate, used to treat low testosterone levels in men and in hormone therapy for transgender men, was manufactured by Sun Pharma at one of the company’s plants in Gujarat.
Testosterone cypionate was a voluntary class II recall, the data showed. A recall is designated class II if exposure to a product may cause temporary or medically-reversible adverse health consequences.